Cite
HARVARD Citation
Edupuganti, S. et al. (2021). Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody. Journal of acquired immune deficiency syndromes. p. . [Online].